Treatment | Preoperative | Before CPB | After CPB | 2 hours after CPB | 24 hours after CPB | 48 hours after CPB | 5.POD | |
---|---|---|---|---|---|---|---|---|
IL-6, pg/ml | HA | Not traceable | Not traceable | 62.9 (10.8, 98.7) | 120.8 (49.0, 160.8) | 111.6 (53.7, 253.5) | 89.0 (61.4, 160.5) | 0.4 (0, 8.3) |
Control | Not traceable | 0 | 63.6 (41.2, 154.9) | 118.7 (68.4, 255.9) | 120.9 (68.0, 198.5) | 67.7 (43.7, 134.5) | 8.2 (0.8, 19.4) | |
P value | 0.3485 | 0.3267 | 0.6781 | 0.9837 | 0.3809 | 0.0999 | ||
IL-10, pg/ml | HA | 0 | 0 | 13.1 (3.3, 18.7) | 5.9 (0.5, 12.9) | 0.3 (0, 4.5) | 0 (0, 1.2) | 0 |
Control | Not traceable | 0 | 18.5 (5.7, 68.0) | 2.3 (0, 11.6) | 0 | Not traceable | Not traceable | |
P value | 0.3485 | 1.0 | 0.1562 | 0.6743 | 0.0347 | 0.0185 | 0.3485 | |
TNFα-LPS, pg/ml | HA | 2216 (1742, 2659) | 2534 (914, 3023) | 40 (1, 82) | Non fec. | Non fec. | 788 (679, 1272) | 1737 (843, 2535) |
Control | 3364 (2579, 4893) | 3403 (1679, 4394) | 77 (34, 316) | Non fec. | Non fec. | 3959 (2088, 4777) | 3358 (3017, 3672) | |
P value | 0.004 | 0.1378 | 0.2049 | 0.0115 | 0.0205 | |||
HMGB1, pg/ml | HA | Non fec. | 0 (0, 28.1) | Non fec. | 5.7 (0, 34.2) | 0 (0, 72.5) | Non fec. | Non fec. |
Control | Non fec. | 48.6 (12.7, 597.3) | Non fec. | 41.5 (4.5, 266.9) | 26.2 (0, 281,2) | Non fec. | Non fec. | |
P value | 0.0208 | 0.1327 | 0.3724 |